-
Mashup Score: 0
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
Source: www.pharmacytimes.comCategories: General Medicine News, PayerTweet
An adjuvanted RSVPreF3 vaccine could prevent nearly 3 million RSV infections in older adults over 3 years, highlighting its potential impact #RSVvaccine #publichealth Read More: https://t.co/3cuf8Fi7OQ